Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Current Liabilities: 2019-2023

Historic Total Current Liabilities for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $78.2 million.

  • ADC Therapeutics' Total Current Liabilities fell 10.70% to $78.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $78.2 million, marking a year-over-year decrease of 10.70%. This contributed to the annual value of $81.9 million for FY2022, which is 10.83% up from last year.
  • As of Q3 2023, ADC Therapeutics' Total Current Liabilities stood at $78.2 million, which was down 2.95% from $80.6 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Total Current Liabilities peaked at $87.6 million during Q3 2022, and registered a low of $31,368 during Q2 2020.
  • Its 3-year average for Total Current Liabilities is $70.9 million, with a median of $73.9 million in 2021.
  • As far as peak fluctuations go, ADC Therapeutics' Total Current Liabilities spiked by 182,008.53% in 2021, and later declined by 10.70% in 2023.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Total Current Liabilities stood at $19.9 million in 2019, then reached $32,563 in 2020, then skyrocketed by 182,008.53% to $73.9 million in 2021, then climbed by 10.83% to $81.9 million in 2022, then decreased by 10.70% to $78.2 million in 2023.
  • Its Total Current Liabilities stands at $78.2 million for Q3 2023, versus $80.6 million for Q2 2023 and $81.1 million for Q1 2023.